Literature DB >> 22609323

Mitochondrial dynamics and neuronal fate in Parkinson's disease.

D Santos1, S M Cardoso.   

Abstract

Along with the impairment of mitochondrial respiration both mitochondrial fission/fusion and mitophagy have been shown to be altered in Parkinson's disease (PD). In both genetic and toxin-induced models of PD an imbalance in mitochondrial morphology is evident, as its correction through modulation of the fission/fusion proteins has been shown to be protective. From the study of the PD-associated genes, namely PINK1 and Parkin, compromised mitochondrial clearance through mitophagy has been associated with the disease etiopathogenesis. Here we propose that an interplay between defective mitochondrial morphology and clearance arises as a crucial player in sentencing neuronal fate in PD.
Copyright © 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609323     DOI: 10.1016/j.mito.2012.05.002

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  21 in total

1.  The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.

Authors:  A R Esteves; M G-Fernandes; D Santos; C Januário; S M Cardoso
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  Water-Soluble Coenzyme Q10 Reduces Rotenone-Induced Mitochondrial Fission.

Authors:  Hai-Ning Li; Mary Zimmerman; Gaolin Z Milledge; Xiao-Lin Hou; Jiang Cheng; Zhen-Hai Wang; P Andy Li
Journal:  Neurochem Res       Date:  2017-02-11       Impact factor: 3.996

3.  Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells.

Authors:  Liliana Rojas-Charry; Mark R Cookson; Andrea Niño; Humberto Arboleda; Gonzalo Arboleda
Journal:  Neurotoxicology       Date:  2014-05-02       Impact factor: 4.294

Review 4.  Pathologic and therapeutic implications for the cell biology of parkin.

Authors:  Rakshita A Charan; Matthew J LaVoie
Journal:  Mol Cell Neurosci       Date:  2015-02-17       Impact factor: 4.314

5.  The Impact of Mitochondrial Fusion and Fission Modulation in Sporadic Parkinson's Disease.

Authors:  Daniel Santos; A Raquel Esteves; Diana F Silva; Cristina Januário; Sandra M Cardoso
Journal:  Mol Neurobiol       Date:  2014-09-14       Impact factor: 5.590

6.  ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression.

Authors:  Yuangang Zhu; Chunyan Wang; Mei Yu; Jie Cui; Liang Liu; Zhiheng Xu
Journal:  Protein Cell       Date:  2013-09-10       Impact factor: 14.870

7.  Alpha Lipoamide Ameliorates Motor Deficits and Mitochondrial Dynamics in the Parkinson's Disease Model Induced by 6-Hydroxydopamine.

Authors:  Bo Zhou; Min Wen; Xin Lin; Yun-Hua Chen; Yun Gou; Yong Li; Yi Zhang; Hong-Wei Li; Lei Tang
Journal:  Neurotox Res       Date:  2017-10-10       Impact factor: 3.911

8.  Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson's-like movement disorder.

Authors:  Wei Lu; Senthilkumar S Karuppagounder; Danielle A Springer; Michele D Allen; Lixin Zheng; Brittany Chao; Yan Zhang; Valina L Dawson; Ted M Dawson; Michael Lenardo
Journal:  Nat Commun       Date:  2014-09-15       Impact factor: 14.919

Review 9.  Function and characteristics of PINK1 in mitochondria.

Authors:  Satoru Matsuda; Yasuko Kitagishi; Mayumi Kobayashi
Journal:  Oxid Med Cell Longev       Date:  2013-02-27       Impact factor: 6.543

Review 10.  Targeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issue.

Authors:  Manuel J Rodríguez; Margot Martínez-Moreno; Francisco J Ortega; Nicole Mahy
Journal:  Oxid Med Cell Longev       Date:  2013-06-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.